Unique targeting of androgen‐dependent and ‐independent AR signaling in prostate cancer to overcome androgen resistance
出版年份 2020 全文链接
标题
Unique targeting of androgen‐dependent and ‐independent AR signaling in prostate cancer to overcome androgen resistance
作者
关键词
-
出版物
FASEB JOURNAL
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2020-07-26
DOI
10.1096/fj.201903167r
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The metastasis suppressor NDRG1 down-regulates the epidermal growth factor receptor via a lysosomal mechanism by up-regulating mitogen-inducible gene 6
- (2019) Sharleen V. Menezes et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Thiosemicarbazones suppress expression of the c-Met oncogene by mechanisms involving lysosomal degradation and intracellular shedding.
- (2019) Kyung Chan Park et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Interplay of the iron-regulated metastasis suppressor NDRG1 with epidermal growth factor receptor (EGFR) and oncogenic signaling
- (2017) Sharleen V. Menezes et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The prostate metastasis suppressor gene NDRG1 differentially regulates cell motility and invasion
- (2017) Anup Sharma et al. Molecular Oncology
- Novel Thiosemicarbazones Inhibit Lysine-Rich Carcinoembryonic Antigen–Related Cell Adhesion Molecule 1 (CEACAM1) Coisolated (LYRIC) and the LYRIC-Induced Epithelial-Mesenchymal Transition via Upregulation of N-Myc Downstream-Regulated Gene 1 (NDRG1)
- (2017) Ruxing Xi et al. MOLECULAR PHARMACOLOGY
- Triptolide Inhibits the AR Signaling Pathway to Suppress the Proliferation of Enzalutamide Resistant Prostate Cancer Cells
- (2017) Yangyang Han et al. Theranostics
- Non-Genomic Actions of the Androgen Receptor in Prostate Cancer
- (2017) Jacky K. Leung et al. Frontiers in Endocrinology
- The novel thiosemicarbazone, di-2-pyridylketone 4-cyclohexyl-4-methyl-3-thiosemicarbazone (DpC), inhibits neuroblastoma growth in vitro and in vivo via multiple mechanisms
- (2016) Zhu-Ling Guo et al. Journal of Hematology & Oncology
- Downregulation of N-myc downstream regulated gene 1 caused by the methylation of CpG islands of NDRG1 promoter promotes proliferation and invasion of prostate cancer cells
- (2015) YALIN LI et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- The Metastasis Suppressor, N-MYC Downstream-regulated Gene-1 (NDRG1), Down-regulates the ErbB Family of Receptors to Inhibit Downstream Oncogenic Signaling Pathways
- (2015) Zaklina Kovacevic et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The renaissance of polypharmacology in the development of anti-cancer therapeutics: Inhibition of the “Triad of Death” in cancer by Di-2-pyridylketone thiosemicarbazones
- (2015) Patric J. Jansson et al. PHARMACOLOGICAL RESEARCH
- Conversion of Androgen Receptor Signaling From a Growth Suppressor in Normal Prostate Epithelial Cells to an Oncogene in Prostate Cancer Cells Involves a Gain of Function in c-Myc Regulation
- (2014) Donald J. Vander Griend et al. International Journal of Biological Sciences
- Dp44mT targets the AKT, TGF-β and ERK pathways via the metastasis suppressor NDRG1 in normal prostate epithelial cells and prostate cancer cells
- (2013) K M Dixon et al. BRITISH JOURNAL OF CANCER
- Enzalutamide: A Review of Its Use in Metastatic, Castration-Resistant Prostate Cancer
- (2013) Mark Sanford DRUGS
- Transcriptional activity of c-Jun is critical for the suppression of AR function
- (2013) Chih-Chao Hsu et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Prostate cancer progression after androgen deprivation therapy: mechanisms of castrate resistance and novel therapeutic approaches
- (2013) T Karantanos et al. ONCOGENE
- The Iron-Regulated Metastasis Suppressor NDRG1 Targets NEDD4L, PTEN, and SMAD4 and Inhibits the PI3K and Ras Signaling Pathways
- (2012) Zaklina Kovacevic et al. ANTIOXIDANTS & REDOX SIGNALING
- The Iron Chelators Dp44mT and DFO Inhibit TGF-β-induced Epithelial-Mesenchymal Transition via Up-Regulation of N-Myc Downstream-regulated Gene 1 (NDRG1)
- (2012) Zhiqiang Chen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Development of proteasome inhibitors as research tools and cancer drugs
- (2012) Alfred L. Goldberg JOURNAL OF CELL BIOLOGY
- Novel Second-Generation Di-2-Pyridylketone Thiosemicarbazones Show Synergism with Standard Chemotherapeutics and Demonstrate Potent Activity against Lung Cancer Xenografts after Oral and Intravenous Administration in Vivo
- (2012) David B. Lovejoy et al. JOURNAL OF MEDICINAL CHEMISTRY
- Persistent androgen receptor-mediated transcription in castration-resistant prostate cancer under androgen-deprived conditions
- (2012) Keith F. Decker et al. NUCLEIC ACIDS RESEARCH
- Phosphorylation of the androgen receptor by PIM1 in hormone refractory prostate cancer
- (2012) S Ha et al. ONCOGENE
- Upregulation of MAPK pathway is associated with survival in castrate-resistant prostate cancer
- (2011) R Mukherjee et al. BRITISH JOURNAL OF CANCER
- Androgen Receptor Enhances p27 Degradation in Prostate Cancer Cells through Rapid and Selective TORC2 Activation
- (2011) Zi Fang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Novel Thiosemicarbazone Iron Chelators Induce Up-Regulation and Phosphorylation of the Metastasis Suppressor N-myc Down-Stream Regulated Gene 1: A New Strategy for the Treatment of Pancreatic Cancer
- (2011) Z. Kovacevic et al. MOLECULAR PHARMACOLOGY
- Noninvasive measurement of androgen receptor signaling with a positron-emitting radiopharmaceutical that targets prostate-specific membrane antigen
- (2011) M. J. Evans et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PSA regulates androgen receptor expression in prostate cancer cells
- (2011) Parmita Saxena et al. PROSTATE
- Iron species-mediated dopamine oxidation, proteasome inhibition, and dopaminergic cell demise: Implications for iron-related dopaminergic neuron degeneration
- (2010) Zhi Dong Zhou et al. FREE RADICAL BIOLOGY AND MEDICINE
- Suppression of the androgen receptor function by quercetin through protein–protein interactions of Sp1, c-Jun, and the androgen receptor in human prostate cancer cells
- (2010) Huiqing Yuan et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- The Iron Chelator Dp44mT Causes DNA Damage and Selective Inhibition of Topoisomerase II in Breast Cancer Cells
- (2009) V. A. Rao et al. CANCER RESEARCH
- Phosphorylation of the androgen receptor is associated with reduced survival in hormone-refractory prostate cancer patients
- (2008) P McCall et al. BRITISH JOURNAL OF CANCER
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now